Biocomposites to showcase innovations in infection management at EBJIS 2024
• Biocomposites-sponsored symposium to focus on how to improve outcomes in complex periprosthetic joint infection (PJI) cases, with insights from leading surgeons• Abstract by Biocomposites’ researchers shows how calcium sulfate beads loaded with antifungals are effective in inhibiting drug-resistant strains of Candida auris
Keele, UK, 23 September 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces its participation as a Platinum Sponsor of the 42nd Annual Meeting of the European Bone & Joint Infection Society (EBJIS), taking place on 26-28 September 2024 at the Palau de Congressos de Barcelona, Spain.
